Moleculin Biotech Inc

NASDAQ:MBRX

1.35

+0.06 (+4.65%)

Earnings Announcements

Moleculin Reports Full Year Financial Results And Provides Programs Update

Published: 03/25/2022 11:14 GMT

Moleculin Biotech Inc (MBRX) - Moleculin Reports Full Year Financial Results and Provides Programs Update.
Moleculin Biotech Inc - Has Sufficient Capital to Fund Operations Into 2024.

Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.